We are live on ! Find out more
BBA

Braun-Bostich & Associates Portfolio holdings

AUM $179M
1-Year Est. Return 21.93%
This Fund
S&P 500
This Quarter Est. Return
+13.38%
1 Year Est. Return
+21.93%
3 Year Est. Return
+59.54%
5 Year Est. Return
+65.25%
10 Year Est. Return
AUM
$102M
AUM Growth
+$23.9M
Cap. Flow
+$11.2M
Cap. Flow %
10.96%
Top 10 Hldgs %
59.82%
Holding
338
New
27
Increased
43
Reduced
25
Closed
9

Sector Composition

Rank Sector Weight
1 Technology 6.95%
2 Consumer Discretionary 6.18%
3 Healthcare 5.07%
4 Consumer Staples 4.28%
5 Communication Services 2.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NWS icon
326
News Corp Class B
NWS
$17.5B
$0 ﹤0.01%
31
OXY icon
327
Occidental Petroleum
OXY
$55.9B
$0 ﹤0.01%
16
PALI icon
328
Palisade Bio
PALI
$367M
0
RRC icon
329
Range Resources
RRC
$8.95B
$0 ﹤0.01%
18
VOD icon
330
Vodafone
VOD
$37.4B
$0 ﹤0.01%
14
WAB icon
331
Wabtec
WAB
$49.3B
$0 ﹤0.01%
1
CNR
332
Core Natural Resources Inc
CNR
$4.45B
$0 ﹤0.01%
94
DALT
333
DELISTED
Anfield Diversified Alternatives ETF
DALT
-524,687
Closed -$3.58M
HSBC.PRA
334
DELISTED
HSBC Holdings PLC, Inc. ADS(1/40 shr. 6.2% Non-Cum. Dlr. Pref. Shrs., Ser.A)
HSBC.PRA
-1,000
Closed -$24K
WPX
335
DELISTED
WPX Energy, Inc.
WPX
$0 ﹤0.01%
22
AGN
336
DELISTED
Allergan plc
AGN
-50
Closed -$9K
JMLP
337
DELISTED
NUVEEN ALL CAP ENERGY MLP OPPORTUNITIES FUND
JMLP
-760
Closed -$1K
RTN
338
DELISTED
Raytheon Company
RTN
-1,014
Closed -$124K

Similar funds

Braun-Bostich & Associates's Q2 2020 Portfolio in Review

As of Q2 2020, Braun-Bostich & Associates held 338 positions worth $102M, up 30% from $78.5M the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Braun-Bostich & Associates deployed $11.2M of net new capital in Q2 2020, opening 27 new positions and adding to 43 existing holdings. Its largest new stake was Idexx Laboratories: 56 shares worth $18K.

By sector, the portfolio is most concentrated in Technology at 6.9% of assets, up from 6.7% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was iShares ESG Aware MSCI USA ETF, an estimated $1M trimmed.

  • Braun-Bostich & Associates's largest Q2 2020 buy was Idexx Laboratories: 56 shares worth $18K.
  • Braun-Bostich & Associates added most to PIMCO Enhanced Short Maturity Active Exchange-Traded Fund in Q2 2020, an estimated $14.2M increase.
  • Braun-Bostich & Associates's biggest Q2 2020 reduction was iShares ESG Aware MSCI USA ETF, cutting an estimated $1M.
  • Braun-Bostich & Associates fully exited Anfield Diversified Alternatives ETF in Q2 2020, selling an estimated $3.58M.
  • Braun-Bostich & Associates's ten largest holdings make up 60% of its $102M portfolio in Q2 2020.
  • Braun-Bostich & Associates opened 27 new positions and closed 9 in Q2 2020.
  • Braun-Bostich & Associates's portfolio value rose 30% quarter-over-quarter to $102M.

Based on Braun-Bostich & Associates's 13F filing for Q2 2020, filed 13 Aug 2020.